Word

MURAL ONCOLOGY

Status

Pending

Status Code

641

Status Date

Monday, January 29, 2024

Serial Number

97929534

Mark Type

3000

Filing Date

Wednesday, May 10, 2023

Trademark Owner History

MURAL ONCOLOGY, INC. - 1st New Owner Before Publication
Alkermes Pharma Ireland Limited - Original Applicant

Classifications

5 Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; therapeutic proteins for use in the manufacture of pharmaceutical preparations; Engineered fusion proteins for medical diagnostic and treatment purposes, namely, fusion proteins created through the use of circular permutation technology, engineered interleukins for optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality and tumor-targeted immunotherapeutic fusion proteins; Cytokine and protein based treatments for oncology-related diseases and disorders; Cytokine and protein fusions medicines having enhanced pharmacokinetics for cancer immunotherapy research and development

44 Providing educational information in the field of medication treatment for oncology to health care providers and patients; providing educational information about pharmaceutical products relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of oncology

42 Research and development of drugs in the fields of oncology-related diseases and disorders; protein engineering for others for use in the development of pharmaceuticals; protein structure modifications for others for use in the development of pharmaceuticals; Clinical and scientific research for medical purposes in the fields of oncology-related diseases and disorders; Clinical and scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer and related diseases and disorders; Providing information and data relating to pharmaceutical, biopharmaceutical, and medical and scientific research and development; Providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; Cytokine engineering and cytokines research and development for use in the development of pharmaceuticals; Research and development of Immune modulating proteins for others for use in the development of pharmaceuticals; Research and development of Cytokine based treatments for oncology-related diseases and disorders; Protein based therapeutic and protein based medicine research and development in the field of pharmaceuticals and biopharmaceuticals for the treatment of cancer and related diseases and disorders; Protein or cytokine based cancer immunotherapy research and development

The mark consists of the word "MURAL" in capitalized font positioned above the word "ONCOLOGY" in capitalized font within the image of a broken circle which surrounds the wording and has a small break or opening to the left of the aforementioned text. White is used for the background but is not claimed as a feature of the mark.
Color is not claimed as a feature of the mark.

Trademark Events

Feb 28, 2024

Automatic Update Of Assignment Of Ownership

Jan 29, 2024

Notification Of Non-Final Action E-Mailed

Jan 29, 2024

Non-Final Action E-Mailed

Jan 29, 2024

Non-Final Action Written

Jan 23, 2024

Assigned To Examiner

Jun 9, 2023

Notice Of Design Search Code E-Mailed

Jun 8, 2023

New Application Office Supplied Data Entered

May 13, 2023

New Application Entered